A detailed history of Jain Global LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Jain Global LLC holds 40,810 shares of FOLD stock, worth $386,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,810
Holding current value
$386,878
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$5.84 - $8.57 $238,330 - $349,741
40,810 New
40,810 $321,000
Q1 2025

May 15, 2025

SELL
$8.16 - $9.85 $10,608 - $12,805
-1,300 Reduced 5.16%
23,910 $195,000
Q4 2024

Feb 14, 2025

BUY
$9.36 - $12.01 $235,965 - $302,772
25,210 New
25,210 $237 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.